Circulating dendritic cells are severely decreased in idiopathic pulmonary fibrosis with a potential value for prognosis prediction

Clin Immunol. 2020 Jun:215:108454. doi: 10.1016/j.clim.2020.108454. Epub 2020 May 5.

Abstract

Dendritic cells (DCs) accumulate in the lung of patients affected by idiopathic pulmonary fibrosis (IPF). We measured the frequencies of circulating conventional CD1c + and CD141+ cells (namely, cDC2 and cDC1) and of plasmacytoid CD303+ DCs in a cohort of 60 therapy naive IPF patients by flow cytometry. Peripheral levels of reactive oxygen species (ROS) and of pro-inflammatory and Th1/Th2 polarizing cytokines were also analyzed. All blood DC subtypes were significantly reduced in IPF patients in comparison to age- and sex-matched controls, while ROS and interleukin (IL-6) levels were augmented. IL-6 expression increased along with disease severity, according to the gender-age-physiology index, and correlated with the frequency of cDC2. IL-6 and cDC2 were not influenced by anti-fibrotic therapies but were associated with a reduced survival, the latter being an independent predictive biomarker of worse prognosis. Deciphering the role of DCs in IPF might provide information on disease pathogenesis and clinical behavior.

Keywords: Dendritic cells; Flow cytometry; Idiopathic pulmonary fibrosis; Interleukin-6; Oxidative burst.

MeSH terms

  • Aged
  • Biomarkers / metabolism
  • Cytokines / metabolism
  • Dendritic Cells / metabolism*
  • Dendritic Cells / pathology*
  • Female
  • Humans
  • Idiopathic Pulmonary Fibrosis / metabolism*
  • Idiopathic Pulmonary Fibrosis / pathology*
  • Male
  • Middle Aged
  • Prognosis

Substances

  • Biomarkers
  • Cytokines